Brian DeSchuytner
Director of Finance/CFO bei MERSANA THERAPEUTICS, INC.
Vermögen: 244 209 $ am 31.03.2024
Profil
Brian DeSchuytner is currently the Senior VP, Chief Operating & Financial Officer at Mersana Therapeutics, Inc. He previously worked as the Vice President-ZEJULA Commercial at Tesaro, Inc. from 2017 to 2019, and as the VP-Global Marketing & Head-Global Brand at Millennium Pharmaceuticals, Inc. from 2009 to 2017.
Mr. DeSchuytner completed his undergraduate degree at Dartmouth College and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.01.2024 | 54 511 ( 0,04% ) | 244 209 $ | 31.03.2024 |
Aktive Positionen von Brian DeSchuytner
| Unternehmen | Position | Beginn |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Director of Finance/CFO | 10.07.2019 |
Ehemalige bekannte Positionen von Brian DeSchuytner
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01.06.2019 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Brian DeSchuytner
| Dartmouth College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
